News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
7,224 Results
Type
Article (594)
Company Profile (2)
Press Release (6628)
Section
Business (2606)
Career Advice (13)
Deals (425)
Drug Delivery (3)
Drug Development (562)
Employer Resources (1)
FDA (97)
Job Trends (213)
News (3560)
Policy (216)
Tag
2024 Bio NC Digital (1)
Academia (37)
Adcomms (1)
Alliances (456)
ALS (1)
Alzheimer's disease (37)
Antibody-drug conjugate (ADC) (2)
Approvals (95)
Artificial intelligence (5)
Autoimmune disease (1)
Bankruptcy (1)
Best Places to Work (182)
Biosimilars (3)
Biotechnology (1)
Breast cancer (3)
Cancer (33)
Cardiovascular disease (4)
Career advice (12)
CAR-T (2)
Cell therapy (6)
Cervical cancer (2)
Clinical research (435)
Collaboration (10)
COVID-19 (26)
CRISPR (5)
C-suite (8)
Data (15)
Denatured (1)
Depression (2)
Diabetes (7)
Diagnostics (65)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (3)
Drug pricing (2)
Drug shortages (1)
Duchenne muscular dystrophy (19)
Earnings (1371)
Editorial (1)
Employer resources (1)
Events (966)
Executive appointments (12)
FDA (111)
Funding (27)
Gene editing (8)
Gene therapy (5)
GLP-1 (13)
Government (35)
Guidances (4)
Healthcare (247)
Huntington's disease (2)
IgA nephropathy (1)
Immunology and inflammation (4)
Indications (1)
Infectious disease (30)
Inflation Reduction Act (1)
Intellectual property (3)
IPO (223)
IRA (2)
Job creations (35)
Job search strategy (12)
Layoffs (5)
Legal (44)
Lung cancer (3)
Lymphoma (2)
Manufacturing (1)
Medical device (143)
Medtech (143)
Mergers & acquisitions (216)
Metabolic disorders (15)
Multiple sclerosis (1)
NASH (1)
Neurodegenerative disease (4)
Neuropsychiatric disorders (2)
Neuroscience (49)
NextGen: Class of 2025 (126)
Non-profit (111)
Northern California (46)
Obesity (8)
Opinion (9)
Pain (1)
Pancreatic cancer (2)
Parkinson's disease (2)
Patents (4)
Patient recruitment (1)
People (668)
Phase I (129)
Phase II (230)
Phase III (181)
Pipeline (63)
Podcasts (1)
Policy (3)
Postmarket research (7)
Preclinical (54)
Press Release (1)
Prostate cancer (1)
Psychedelics (1)
Radiopharmaceuticals (6)
Rare diseases (12)
Real estate (75)
Regulatory (168)
Reports (2)
Research institute (20)
Resumes & cover letters (1)
RSV (2)
Schizophrenia (2)
Series A (6)
Series B (1)
Sickle cell disease (3)
Southern California (45)
Spinal muscular atrophy (4)
Startups (58)
United States (379)
Vaccines (5)
Weight loss (4)
Women's health (1)
Date
Today (4)
Last 7 days (9)
Last 30 days (54)
Last 365 days (633)
2025 (204)
2024 (651)
2023 (720)
2022 (737)
2021 (637)
2020 (580)
2019 (586)
2018 (405)
2017 (389)
2016 (354)
2015 (410)
2014 (258)
2013 (231)
2012 (195)
2011 (174)
2010 (136)
Location
Africa (9)
Arizona (1)
Arkansas (1)
Asia (309)
Australia (117)
California (100)
Canada (29)
China (4)
Colorado (2)
Connecticut (2)
Delaware (3)
Europe (1057)
Florida (26)
Georgia (3)
Illinois (6)
Indiana (2)
Japan (2)
Kansas (2)
Maine (1)
Maryland (7)
Massachusetts (89)
Michigan (2)
Minnesota (6)
Missouri (1)
Nebraska (1)
New Jersey (18)
New York (54)
North Carolina (15)
Northern California (46)
Ohio (2)
Pennsylvania (27)
Rhode Island (1)
South America (10)
Southern California (45)
Texas (13)
Utah (5)
Washington D.C. (1)
Washington State (3)
7,224 Results for "catalyst orthoscience".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Catalyst OrthoScience Announces Amy Ables, Ph.D. as Chief Strategy Officer
Catalyst OrthoScience Inc. (Catalyst), a medical device company focused on the upper extremity orthopedics market, has appointed Amy Ables, Ph.D . as chief strategy officer of the organization, effective immediately.
November 20, 2023
·
2 min read
Business
Catalyst OrthoScience Announces Mark Quick as Chief Financial Officer
Catalyst OrthoScience Inc., a medical device company focused on the upper extremity orthopedics market, has appointed seasoned medical device leader Mark Quick as chief financial officer of the organization, effective immediately.
June 6, 2023
·
2 min read
Press Releases
Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts
March 25, 2025
·
28 min read
Press Releases
Agilent Research Catalyst Award Presented to Columbia University for Professor Pawel Muranski
March 19, 2025
·
4 min read
Press Releases
Health Catalyst to Participate in Upcoming Investor Conference
January 30, 2025
·
1 min read
Press Releases
Catalyst Pharmaceuticals to Participate in the Barclays 27th Annual Global Healthcare Conference
March 4, 2025
·
2 min read
Press Releases
Catalyst Pharmaceuticals Announces Health Canada’s Acceptance of AGAMREE® New Drug Submission with Priority Review for Sub-Licensee Kye Pharmaceuticals
April 9, 2025
·
5 min read
Catalyst Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference 2024
Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX) today announced that Richard J. Daly, President and CEO of Catalyst, along with other members of Catalyst’s management team, will participate at the upcoming Jefferies Global Healthcare Conference 2024 on Wednesday, June 5, 2024, in New York.
May 28, 2024
·
3 min read
Business
Catalyst Oncology and Imerman Angels announce collaboration
Starting on June 2 , National Cancer Survivors Day, Catalyst Oncology, the biotech-focused oncology CRO brand of Catalyst Clinical Research, will start a collaboration with Imerman Angels , a renowned nonprofit organization providing free, personalized one-on-one cancer support.
May 31, 2024
·
2 min read
Press Releases
Catalyst Pharmaceuticals Reports Record Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
February 27, 2025
·
17 min read
1 of 723
Next
